Approachable, physician-led oversight for decentralized and hybrid trials — integrating multiple platforms, coordinating home-health teams, and safeguarding participants with rapid adverse event response and inspection-ready quality.
Decentralized clinical trials (DCTs) bring parts of the study to participants — through tele-visits, eConsent, home-health visits, local labs, and connected devices. This approach can reduce travel burden, widen access, and support diversity in enrollment. It also introduces new operational needs: multi-platform coordination, remote monitoring, and clear safety escalation.
Flexible visits at home or local clinics; transparent schedules and reminders improve engagement and retention.
Telemedicine, wearables, ePRO/eDiary, and remote diagnostics integrated into a cohesive workflow.
Inspection-ready documentation, GCP-aligned processes, and robust audit trails across platforms.
Clear clinical oversight and rapid AE response so remote participation never compromises safety
As a physician-investigator, I provide hands-on oversight for decentralized and hybrid trials — partnering with sponsors, CROs, and site teams to make remote operations safe, simple, and compliant.
Selection and integration of tele-visit, eConsent, ePRO, wearables, and home-health logistics — with data flow mapping and SOPs.
Risk-based, remote SDV/SDR strategy with timely query resolution, protocol adherence checks, and data completeness tracking.
Clear roles, training modules, and documentation for mobile nurses and local providers; aligned with PI oversight.
Near real-time clinical escalation for AEs, with coordinated communication among local providers, home-health teams, and sponsor safety.
GCP-aligned SOPs for decentralized workflows; inspection-ready documentation and mock-audit support.
Enrollment, visit adherence, data completeness, query turnaround, AE timelines — visible to stakeholders at a glance.
As a physician-investigator, I provide hands-on oversight for decentralized and hybrid trials — partnering with sponsors, CROs, and site teams to make remote operations safe, simple, and compliant.
Selection and integration of tele-visit, eConsent, ePRO, wearables, and home-health logistics — with data flow mapping and SOPs.
Selection and integration of tele-visit, eConsent, ePRO, wearables, and home-health logistics — with data flow mapping and SOPs.
Selection and integration of tele-visit, eConsent, ePRO, wearables, and home-health logistics — with data flow mapping and SOPs.
Selection and integration of tele-visit, eConsent, ePRO, wearables, and home-health logistics — with data flow mapping and SOPs.
Selection and integration of tele-visit, eConsent, ePRO, wearables, and home-health logistics — with data flow mapping and SOPs.
Selection and integration of tele-visit, eConsent, ePRO, wearables, and home-health logistics — with data flow mapping and SOPs.
Our team bridges clinical expertise with data science and digital health technology, designing AI-enabled workflows and integrated platforms for real-time data entry, analytics, and oversight. We help research organizations modernize infrastructure and improve efficiency across multi-site and decentralized trials.
Choose a flexible model that meets your study’s phase and pace. I plug into your existing CRO and site network while maintaining clear PI/medical oversight.
Assess decentralization fit, platform needs, home-health logistics, and monitoring strategy; define risks and mitigations.
Platform configuration, SOPs, training, and data-flow mapping with go-live readiness checks.
Remote monitoring governance, AE escalation, data quality reviews, and regular sponsor/CRO touchpoints.
Answers to common questions about working with us.
Our physicians can significantly enhance a decentralized clinical trial by providing specialist oversight without requiring participants to travel to a research site. At Neurocare Health, all physicians are multi-state licensed, GCP-credentialed, and board-certified, enabling high-quality neurological assessments across geographically dispersed populations. Through secure telemedicine platforms, our clinicians perform virtual neurological exams, adjudicate symptoms, review home-collected ECG and laboratory data, complete scales such as the C-SSRS and CGI, and deliver rapid AE/SAE evaluations. This approach preserves the clinical rigor of in-person neurology oversight while improving access, participant retention, and the overall integrity of trial data.
Neurocare Health physicians partner seamlessly with both CROs and Sponsors as independent contractors, delivering the specialized neurological oversight and scientific direction essential to high-quality clinical research. Our multi-state licensed, GCP-credentialed, board-certified clinicians integrate into existing study teams to support protocol development, endpoint refinement, medical monitoring, safety review, adjudication, and complex clinical decision-making. Whether embedded within a CRO framework or engaged directly by a Sponsor, our physicians provide unbiased, expert guidance that strengthens data integrity, enhances participant safety, and ensures that neuroscience programs are executed with precision and clinical rigor.
Participant safety and privacy are safeguarded in decentralized clinical trials through a combination of structured clinical oversight, secure technology, and regulated workflows. At Neurocare Health, remote safety monitoring is led by multi-state licensed, GCP-credentialed, board-certified neurologists who review symptoms, conduct virtual exams, assess AEs/SAEs, and evaluate ECG and laboratory results in real time. Participants connect through encrypted telemedicine platforms that meet HIPAA and 21 CFR Part 11 standards, ensuring that all medical information is transmitted and stored securely. Identity confirmation, controlled access, and audit-trail documentation further protect participant privacy. Continuous communication with home-health teams, CRO safety units, and site personnel ensures rapid escalation when needed, allowing us to maintain the same level of vigilance, clinical rigor, and participant protection as an in-person trial—while leveraging the flexibility and reach of decentralized research.
Neurology participants often face mobility, transportation, or fatigue-related challenges. DCTs reduce travel burden, increase accessibility, and improve retention—while still allowing high-quality neurological assessments through remote platforms and hybrid site-based visits when needed.
